These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19551767)

  • 1. Melatonin as a potential therapeutic agent in psychiatric illness.
    Maldonado MD; Reiter RJ; Pérez-San-Gregorio MA
    Hum Psychopharmacol; 2009 Jul; 24(5):391-400. PubMed ID: 19551767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Melatonin therapeutic use in psychiatry: a 39 year bibliographic study].
    Morera A; Henry M; Abreu P; Gracia R
    Actas Esp Psiquiatr; 2006; 34(5):344-51. PubMed ID: 16991024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin as pharmacologic support in burn patients: a proposed solution to thermal injury-related lymphocytopenia and oxidative damage.
    Maldonado MD; Murillo-Cabezas F; Calvo JR; Lardone PJ; Tan DX; Guerrero JM; Reiter RJ
    Crit Care Med; 2007 Apr; 35(4):1177-85. PubMed ID: 17312564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological potentiality of melatonin].
    Muñoz Barragán L
    An R Acad Nac Med (Madr); 2002; 119(3):463-77. PubMed ID: 12812036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of melatonin in the immuno-neuro-psychology of mental disorders.
    Maldonado MD; Pérez-San-Gregorio MA; Reiter RJ
    Recent Pat CNS Drug Discov; 2009 Jan; 4(1):61-9. PubMed ID: 19149715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Melatonin. A clinical-pharmacological assessment].
    Bertsche T; Schulz M
    Med Monatsschr Pharm; 2004 Feb; 27(2):39-48. PubMed ID: 15008273
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic potential of melatonin ligands.
    Delagrange P; Boutin JA
    Chronobiol Int; 2006; 23(1-2):413-8. PubMed ID: 16687314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy.
    Witt-Enderby PA; Radio NM; Doctor JS; Davis VL
    J Pineal Res; 2006 Nov; 41(4):297-305. PubMed ID: 17014686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry.
    Pacchierotti C; Iapichino S; Bossini L; Pieraccini F; Castrogiovanni P
    Front Neuroendocrinol; 2001 Jan; 22(1):18-32. PubMed ID: 11141317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin: therapeutic and clinical utilization.
    Altun A; Ugur-Altun B
    Int J Clin Pract; 2007 May; 61(5):835-45. PubMed ID: 17298593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin: new applications in clinical and veterinary medicine, plant physiology and industry.
    Reiter RJ; Coto-Montes A; Boga JA; Fuentes-Broto L; Rosales-Corral S; Tan DX
    Neuro Endocrinol Lett; 2011; 32(5):575-87. PubMed ID: 22167140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin: Pharmacology, Functions and Therapeutic Benefits.
    Tordjman S; Chokron S; Delorme R; Charrier A; Bellissant E; Jaafari N; Fougerou C
    Curr Neuropharmacol; 2017 Apr; 15(3):434-443. PubMed ID: 28503116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future of melatonin as a therapeutic agent.
    Karasek M; Reiter RJ; Cardinali DP; Pawlikowski M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():118-21. PubMed ID: 12019364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disorders.
    Giri A; Mehan S; Khan Z; Das Gupta G; Narula AS; Kalfin R
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3867-3895. PubMed ID: 38225412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic potential of melatonin: a review of the science.
    Malhotra S; Sawhney G; Pandhi P
    MedGenMed; 2004 Apr; 6(2):46. PubMed ID: 15266271
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphocytes as a neural probe: potential for studying psychiatric disorders.
    Gladkevich A; Kauffman HF; Korf J
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):559-76. PubMed ID: 15093964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The neuroinflammation hypothesis of psychiatric disorders].
    Monji A
    Seishin Shinkeigaku Zasshi; 2012; 114(2):124-33. PubMed ID: 22568115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives on the use of melatonin to reduce cytotoxic and genotoxic effects of methacrylate-based dental materials.
    Blasiak J; Kasznicki J; Drzewoski J; Pawlowska E; Szczepanska J; Reiter RJ
    J Pineal Res; 2011 Sep; 51(2):157-62. PubMed ID: 21470304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders.
    Hardeland R
    Curr Opin Investig Drugs; 2009 Jul; 10(7):691-701. PubMed ID: 19579175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ramelteon: a review of its therapeutic potential in sleep disorders.
    Pandi-Perumal SR; Srinivasan V; Spence DW; Moscovitch A; Hardeland R; Brown GM; Cardinali DP
    Adv Ther; 2009 Jun; 26(6):613-26. PubMed ID: 19568703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.